Tim Henkel
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 8
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility 5
- Antimicrobial Resistance in Staphylococcus 3
- Clinical Biochemistry top 2%
- Virology top 5%
-
- Antibiotics Pharmacokinetics and Efficacy 9
-
- Urinary Tract Infections Management 5
- Influenza Virus Research Studies 3
-
- Nephrotoxicity and Medicinal Plants 4
-
- Immune Cell Function and Interaction 3
- Co-authors
- Beth P. GoldsteinJames A. DowellElyse SeltzerV L BracialeRay HachemRabih O. DarouicheJosé A. VázquezArnold Lentnek
- Journals
- The Journal of Immunology (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)Open Forum Infectious Diseases (4 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Tim Henkel
28 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Applied Microbiology and Biotechnology 93
- Molecular Medicine 218
- Infectious Diseases 784
- Clinical Biochemistry 223
- Virology 116
Countries citing papers authored by Tim Henkel
This map shows the geographic impact of Tim Henkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Henkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Henkel more than expected).
Fields of papers citing papers by Tim Henkel
This network shows the impact of papers produced by Tim Henkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Henkel. The network helps show where Tim Henkel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tim Henkel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | Cefepime–Taniborbactam in Complicated Urinary Tract Infectionbreakdown → | 2024 | 67 |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 11 | |
| 6 | 2012 | 77 | |
| 7 | 2011 | 3 | |
| 8 | 2010 | 2 | |
| 9 | 2005 | 232 | |
| 10 | 2004 | 169 | |
| 11 | 2004 | 142 | |
| 12 | 2004 | 10 | |
| 13 | A clinical mass balance study of anidulafungin showing complete fecal elimination | 2003 | 8 |
| 14 | Dalbavancin pharmacokinetics in subjects with mild or moderate hepatic impairment | 2003 | 1 |
| 15 | 2003 | 198 | |
| 16 | 2001 | 17 | |
| 17 | 1999 | 35 | |
| 18 | 1992 | 109 | |
| 19 | 1987 | 70 | |
| 20 | 1984 | 72 |
About Tim Henkel
Tim Henkel is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Resistance in Bacteria (8 papers), Antifungal resistance and susceptibility (5 papers), Urinary Tract Infections Management (5 papers), Nephrotoxicity and Medicinal Plants (4 papers), Influenza Virus Research Studies (3 papers), Immune Cell Function and Interaction (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (93 citations), Molecular Medicine (218 citations) and Infectious Diseases (784 citations). Tim Henkel has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Beth P. Goldstein, James A. Dowell, Elyse Seltzer, V L Braciale, Ray Hachem, Rabih O. Darouiche, José A. Vázquez, Arnold Lentnek, Hend Hanna and Issam Raad. Their work appears in journals such as The Journal of Immunology, Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Clinical Infectious Diseases and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.